Whitepapers

Whitepaper Nov 2, 2026

Closing the Evidence Gap: Integrating Patient Experience Data and Real-World Evidence

Whitepaper Oct 30, 2026

Feasibility for Retrospective Observational Secondary RWD Studies is Not One-Size-Fits-All

Whitepaper Oct 29, 2026

The Evidence You Build Today Could Determine the Access You Earn Tomorrow

Whitepaper Oct 26, 2026

In-trial Interviews: Assessing the Landscape of Benefits and Opportunities

View Oct 23, 2026

Publicity Is Not Policy

Whitepaper Oct 13, 2026

Regulatory-Ready Feasibility Frameworks – Lumanity’s Approach to Secondary Data Source Assessment for PASS

Whitepaper Oct 13, 2026

Most Favored Nation Drug Pricing: Three Reasons the Headlines May Be Bigger Than the Drug Pricing Impact

A confident female leader engages a diverse team in a professional workshop, promoting teamwork and fresh ideas in a bright office environment.

Whitepaper Oct 7, 2026

Finding Common Ground: A Practical Framework for Multi-Stakeholder Co-Creation

Whitepaper Sep 29, 2026

Approval is a Milestone, Access is the Mission

Whitepaper Sep 25, 2026

The New Rules of AdCom Success

Whitepaper Jul 28, 2026

Preparing for Universal Orphan Drug JCA Submissions

Whitepaper Jul 23, 2026

Did the Rules of Pharma Market Research Change Overnight?

Whitepaper Jul 21, 2026

Stop Guessing: How to Choose and Execute the Right Validation Design for Cases, Exposures, and Outcomes in Real-World Data

Whitepaper Jul 9, 2026

Beyond Claims: Dutch and Nordic Linked Data as European References for Precision Endpoints and High Impact Real-World Decisions

Whitepaper Jun 26, 2026

Unlocking the 505(b) (2) Pathway: A Practical Guide to Success

Whitepaper Jun 9, 2026

CAR‑T in Autoimmune Disease: What’s Changing and What Comes Next

1 2 3 … 7